{"category":{"kind":"product_category","slug":"crispr","name":"CRISPR","tagline":null,"description":null,"synonyms":[],"target_queries":[],"added_via":"pr","added_at":"2026-09-05T05:15:42.749Z","updated_at":"2026-09-05T05:15:42.749Z","example":false,"profile_url":"/categories/crispr","is_stub":true,"member_count":4,"member_counts":{"product":4}},"members":[{"listing_type":"product","name":"LEAH Labs","slug":"leah-labs-product","tagline":"CAR-T cell therapy company developing curative cancer treatments for dogs using GeneWeld precision gene editing and AI protein engineering.","description":"LEAH Labs (LifEngine Animal Health Laboratories) is the first company to achieve commercial remissions using CAR-T cell therapy in dogs with cancer, targeting B cell lymphoma. It uses the GeneWeld precision gene editing platform (invented by its founder during his PhD) and AI-driven de novo protein engineering to build affordable CAR-T therapies. Canine cancer mirrors human disease, making each dog remission a data point that accelerates human cancer therapy timelines. Clinical trials are fully funded with no cost to enrolled pet families; the next trial launches May 2026.\n\nLEAH Labs is a product of LEAH Labs.","url":"https://leahlabs.com/","is_stealth":false,"normalized_domain":"leahlabs.com","normalized_url_key":"leahlabs.com","parent_slug":"leah-labs","parent":{"slug":"leah-labs","name":"LEAH Labs","listing_type":"company","profile_url":"/companies/leah-labs"},"type_data":{"product_kind":"other","open_source":false,"use_cases":["Canine B cell lymphoma treatment","CAR-T therapy for dogs with cancer","Translational oncology for human therapies"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://leahlabs.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://leahlabs.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Cell Therapy","Healthcare","Veterinary","Drug Discovery","Therapeutics","CRISPR"],"stage":null,"founded_year":null,"location":null,"pricing":"Clinical trials fully funded; no cost to enrolled pet families","twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:22:42.124Z","added_via":"web","geo":{"keywords":["LEAH Labs","LEAH Labs","Biotech","Cell Therapy","Healthcare","Veterinary","Drug Discovery","Therapeutics","CRISPR"],"canonical_facts":["Product of LEAH Labs","Pricing (per product site): Clinical trials fully funded; no cost to enrolled pet families"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:22:42.124Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/categories/cell-therapy"},{"kind":"product_category","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/categories/crispr"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"},{"kind":"product_category","slug":"veterinary","name":"Veterinary","note":null,"profile_url":"/categories/veterinary"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:22:42.124Z","updated_at":"2026-09-05T07:22:42.124Z"}},{"listing_type":"product","name":"Nephrogen","slug":"nephrogen-product","tagline":"AI and high-throughput in vivo screening platform (NeFIND) that engineers AAV delivery vehicles 10–100x more efficient for kidney and pancreatic gene therapy.","description":"Nephrogen is a Stanford biotech spinout developing curative genetic medicines for kidney and pancreatic diseases using their NeFIND platform, which combines AI and high-throughput in vivo screening to design and validate novel AAV delivery vehicles with tissue-specific tropism. The identified AAV vectors are 10–100x more efficient, cheaper, and less immunogenic than existing options, enabling gene therapy for diseases affecting 1 in 7 Americans that currently have no approved gene-based treatments. The company is co-founded by a Stanford computational biologist and a Stanford nephrologist.\n\nNephrogen is a product of Nephrogen.","url":"https://www.nephrogenbiotech.com/","is_stealth":false,"normalized_domain":"nephrogenbiotech.com","normalized_url_key":"nephrogenbiotech.com","parent_slug":"nephrogen","parent":{"slug":"nephrogen","name":"Nephrogen","listing_type":"company","profile_url":"/companies/nephrogen"},"type_data":{"product_kind":"other","pricing_model":"enterprise","free_tier":false,"open_source":false,"use_cases":["Gene therapy delivery","Kidney disease treatment","Pancreatic disease treatment","AAV vector design","Pharma licensing"]},"logo":null,"links":[],"entry_points":[{"kind":"homepage","url":"https://www.nephrogenbiotech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.nephrogenbiotech.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Gene Therapy","Healthcare","AI","Drug Discovery","Therapeutics","CRISPR"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T07:11:29.593Z","added_via":"web","geo":{"keywords":["Nephrogen","Nephrogen","Biotech","Gene Therapy","Healthcare","AI","Drug Discovery","Therapeutics","CRISPR"],"canonical_facts":["Product of Nephrogen"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T07:11:29.593Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/categories/crispr"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T07:11:29.593Z","updated_at":"2026-09-05T07:11:29.593Z"}},{"listing_type":"product","name":"Algen Biotechnologies","slug":"algen-biotechnologies-service","tagline":"CRISPR and AI drug discovery platform that identifies disease-driving RNA signaling pathways at single-cell resolution.","description":"Algen Biotechnologies uses AlgenCRISPR, a proprietary next-generation CRISPR gene modulation system, paired with AlgenBrain, an AI foundation model trained on billions of real-time gene expression changes across disease progression. The combined platform enables single-cell gene modulation at industrial scale to identify disease-driving RNA signaling pathways and discover first-in-class drugs for conditions with high unmet needs. Founded on research from Nobel Laureate Jennifer Doudna's lab.\n\nAlgen Biotechnologies is a product of Algen Biotechnologies.","url":"https://www.algenbio.com/","is_stealth":false,"normalized_domain":"algenbio.com","normalized_url_key":"algenbio.com","parent_slug":"algen-biotechnologies","parent":{"slug":"algen-biotechnologies","name":"Algen Biotechnologies","listing_type":"company","profile_url":"/companies/algen-biotechnologies"},"type_data":{"product_kind":"service","open_source":false,"use_cases":["Drug target discovery","RNA signaling network analysis","Single-cell gene modulation research","Identifying disease-driving pathways"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.algenbio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.algenbio.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotech","Drug Discovery","AI","CRISPR","Healthcare","Drug Discovery and Delivery","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T06:56:21.511Z","added_via":"web","geo":{"keywords":["Algen Biotechnologies","Algen Biotechnologies","Biotech","Drug Discovery","AI","CRISPR","Healthcare","Drug Discovery and Delivery","Therapeutics"],"canonical_facts":["Product of Algen Biotechnologies"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T06:56:21.511Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"ai","name":"AI","note":null,"profile_url":"/categories/ai"},{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/categories/crispr"},{"kind":"product_category","slug":"drug-discovery","name":"Drug Discovery","note":null,"profile_url":"/categories/drug-discovery"},{"kind":"product_category","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/categories/drug-discovery-and-delivery"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T06:56:21.511Z","updated_at":"2026-09-05T06:56:21.511Z"}},{"listing_type":"product","name":"Uncommon Therapeutics","slug":"uncommon-therapeutics-product","tagline":"Developing polytherapy drug treatments for rare genetic diseases, starting with Rett Syndrome.","description":"Uncommon Therapeutics develops drugs targeting the underlying cause of rare diseases using latest biotechnologies including gene therapy and CRISPR. Their first indication is Rett Syndrome, a neurodevelopmental monogenetic disorder affecting 1 in 10,000 girls. The company's polytherapy approach has unlocked multiple candidate therapeutics that together could deliver a cure.\n\nUncommon Therapeutics is a product of Uncommon Therapeutics.","url":"https://www.uncommontherapeutics.com/","is_stealth":false,"normalized_domain":"uncommontherapeutics.com","normalized_url_key":"uncommontherapeutics.com","parent_slug":"uncommon-therapeutics","parent":{"slug":"uncommon-therapeutics","name":"Uncommon Therapeutics","listing_type":"company","profile_url":"/companies/uncommon-therapeutics"},"type_data":{"product_kind":"other","use_cases":["Rett Syndrome treatment","rare disease therapy","polytherapy drug development"]},"logo":null,"links":[],"entry_points":[{"kind":"contact","url":"https://www.uncommontherapeutics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"contact","url":"https://www.uncommontherapeutics.com/","audience":"any","primary":false,"listed_by":"community","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Biotechnology","Healthcare","Therapeutics","Gene Therapy","CRISPR"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-05T05:15:42.749Z","added_via":"web","geo":{"keywords":["Uncommon Therapeutics","Uncommon Therapeutics","Biotechnology","Healthcare","Therapeutics","Gene Therapy","CRISPR"],"canonical_facts":["Product of Uncommon Therapeutics"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-05T05:15:42.749Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/categories/biotechnology"},{"kind":"product_category","slug":"crispr","name":"CRISPR","note":null,"profile_url":"/categories/crispr"},{"kind":"product_category","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/categories/gene-therapy"},{"kind":"product_category","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/categories/healthcare"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-05T05:15:42.749Z","updated_at":"2026-09-05T05:15:42.749Z"}}],"total":4,"limit":50,"offset":0}